|
Novartis AG
(NYSE: NVS)
|
8:00 PM UTC, 09/11/26 | |||
|---|---|---|---|---|
| Last: $137.16 | Change: -0.32 | %Change: -0.23% | Volume: 2,353,808 | |
| Open: | $ 139.31 | Volume: | 2,353,808 | |
|---|---|---|---|---|
| High: | $ 139.55 | Yield(%) | 2.25 | |
| Low: | $ 137.00 | P/E Ratio (ttm): | 20.62 | |
| Dividend ($): | 3.08 | Market Cap ($): | 251.66B | |
| EPS ($) | 6.67 | Shares Out: | 1.83B |
| % Price Change (last 4 weeks): | -9.39 |
|---|---|
| % Price Change (last 13 weeks): | -10.68 |
| % Price Change (last 26 weeks): | -10.87 |
| % Price Change (last 52 weeks): | 7.66 |
| % Price Change (year to date): | -0.28 |
| Return on Equity (%): | 31.17 |
|---|---|
| Return on Assets (%): | 12.64 |
| Return on Invested Capital (%): | 16.88 |
| Gross Profit Margin (%): | 75.02 |
|---|---|
| Net Profit Margin (%): | 25.64 |
| Operating Profit Margin (%): | 31.15 |
|
|
|
| 50-day Moving Average: | $154.14 |
|---|---|
| 200-day Moving Average: | $149.94 |
| Avg. Daily Vol. (last 50 days): | 1,940,740 |
| Avg. Daily Vol. (last 200 days): | 1,944,506 |
| 52-wk high: | $170.46 |
| 52-wk low: | $121.57 |
| Bid: | $139.90 |
| Ask: | $140.00 |
|
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
|
| Earnings (1year) ($): | 6.67 |
|---|---|
| Annual Dividend ($): | 3.08 |
| Current P/E Ratio (ttm): | 20.62 |
| Book Value ($): | 24.18 |
| Cash Flow ($): | 10.17 |
| Price/Earnings (x): | 20.62 |
|---|---|
| Price/Sales (x): | 4.92 |
| Price/Book (x): | 5.70 |
| Price/Cash Flow (x): | 14.01 |
| Quick Ratio (x): | 0.89 |
|---|---|
| Current Ratio (x): | 1.12 |
| LT Debt/Equity (x): | 64.15 |
| Total Debt/Equity (x): | 76.69 |